We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 24th:
Covenant Transportation Group, Inc. : This truckload transportation services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 10.9% over the last 60 days.
Covenant Transportation Group, Inc. Price and Consensus
Penske Automotive Group, Inc. (PAG - Free Report) : This transportation services company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 4.1% over the last 60 days.
Knoll, Inc. : This seller of commercial and residential furniture has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.4% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Value Stocks to Buy for August 24th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 24th:
Covenant Transportation Group, Inc. : This truckload transportation services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 10.9% over the last 60 days.
Covenant Transportation Group, Inc. Price and Consensus
Covenant Transportation Group, Inc. price-consensus-chart | Covenant Transportation Group, Inc. Quote
Covenant has a price-to-earnings ratio (P/E) of 13.87 compared with 17.80 for the industry. The company possesses a Value Score of A.
Covenant Transportation Group, Inc. PE Ratio (TTM)
Covenant Transportation Group, Inc. pe-ratio-ttm | Covenant Transportation Group, Inc. Quote
Penske Automotive Group, Inc. (PAG - Free Report) : This transportation services company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 4.1% over the last 60 days.
Penske Automotive Group, Inc. Price and Consensus
Penske Automotive Group, Inc. price-consensus-chart | Penske Automotive Group, Inc. Quote
Penske Automotive has a price-to-earnings ratio (P/E) of 9.82, compared with 13.70 for the industry. The company possesses a Value Score of A.
Penske Automotive Group, Inc. PE Ratio (TTM)
Penske Automotive Group, Inc. pe-ratio-ttm | Penske Automotive Group, Inc. Quote
Knoll, Inc. : This seller of commercial and residential furniture has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.4% over the last 60 days.
Knoll, Inc. Price and Consensus
Knoll, Inc. price-consensus-chart | Knoll, Inc. Quote
Knoll has a price-to-earnings ratio (P/E) of 12.85, compared with 14.00 for the industry. The company possesses a Value Score of A.
Knoll, Inc. PE Ratio (TTM)
Knoll, Inc. pe-ratio-ttm | Knoll, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>